Resistance to anti-xenogeneic response by combining α-Gal silencing with HO-1 upregulation

Transplant Immunology

Volumn 19, Issue 3-4, 2008, Pages 202-208

  Zhu, Min ^a   Zhang, Wei ^b   Liu, Fang ^b   Wang, Lu ^a   Liu, Bin ^a   Chen, Dong ^a   Zhu, Xue Hai ^a   Zhang, Wei Jie ^a   Ichim, Thomas E ^c   Chen, Zhi Shui ^a   Zhou, Ping ^a   Chen, Shi ^a   Chen, Gang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b Wuhan No 3 Hospital   (China)

^c MediStem Laboratories Inc   (United States)

Author keywords

Accommodation; Endothelial cell; RNA interference; Xenotransplantation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALPHA 1,3 GALACTOSYLTRANSFERASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITOPE; GALACTOSYLGALACTOSE; GRIFFONIA SIMPLICIFOLIA ISOLECTIN B4; HEME OXYGENASE 1; LECTIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL PROTECTION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; GRAFT SURVIVAL; GRIFFONIA; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; XENOTRANSPLANTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIBODIES, HETEROPHILE; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL LINE; CHROMONES; DISACCHARIDES; DRUG COMBINATIONS; ENDOTHELIAL CELLS; GALACTOSYLTRANSFERASES; GENE SILENCING; HEME OXYGENASE-1; HUMANS; MORPHOLINES; PLANT LECTINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SWINE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 48349112626     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.06.002     Document Type: Article

References (39)

1. Sandrin M.S., Vaughan H.A., Dabkowski P.L., and McKenzie I.F. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A 90 (1993) 11391-11395
2. Sandrin M.S., Fodor W.L., Mouhtouris E., Osman N., Cohney S., Rollins S.A., et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1 (1995) 1261-1267
3. Takahashi K., Saito K., Takahara S., Okuyama A., Tanabe K., Toma H., et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 (2004) 1089-1096
4. Hanto D.W., Fecteau A.H., Alonso M.H., Valente J.F., and Whiting J.F. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 9 (2003) 22-30
5. Rozman P., Kosir A., and Bohinjec M. Is the ABO incompatibility a risk factor in bone marrow transplantation?. Transpl Immunol 14 (2005) 159-169
6. Galili U., Anaraki F., Thall A., Hill-Black C., and Radic M. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 82 (1993) 2485-2493
7. Galili U. Anti-Gal antibody prevents xenotransplantation. Sci Med (1998) 28
8. Economidou J., Hughes-Jones N.C., and Gardner B. Quantitative measurements concerning A and B antigen sites. Vox Sang 12 (1967) 321-328
9. Zhu M., Wang S.S., Xia Z.X., Cao R.H., Chen D., Huang Y.B., et al. Inhibition of xenogeneic response in porcine endothelium using RNA interference. Transplantation 79 (2005) 289-296
10. Bach F.H., Ferran C., Hechenleitner P., Mark W., Koyamada N., Miyatake T., et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196-204
11. Salama A.D., Delikouras A., Pusey C.D., Cook H.T., Bhangal G., Lechler R.I., et al. Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant 1 (2001) 260-269
12. Wang N., Lee J.M., Tobiasch E., Csizmadia E., Smith N.R., Gollackes B., et al. Induction of xenograft accommodation by modulation of elicited antibody responses1 2. Transplantation 74 (2002) 334-345
13. Soares M.P., Lin Y., Anrather J., Csizmadia E., Takigami K., Sato K., et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4 (1998) 1073-1077
14. Numazawa S., Yamada H., Furusho A., Nakahara T., Oguro T., and Yoshida T. Cooperative induction of c-fos and heme oxygenase gene products under oxidative stress in human fibroblastic cells. Exp Cell Res 237 (1997) 434-444
15. Hancock W.W., Buelow R., Sayegh M.H., and Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4 (1998) 1392-1396
16. Narayanan K., Jaramillo A., Phelan D.L., and Mohanakumar T. Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol 34 (2004) 2303-2312
17. Soares M.P., Lin Y., Sato K., Stuhlmeier K.M., and Bach F.H. Accommodation. Immunol Today 20 (1999) 434-437
18. Grehan J.F., Levay-Young B.K., Benson B.A., Abrahamsen M.S., and Dalmasso A.P. Alpha Gal ligation of pig endothelial cells induces protection from complement and apoptosis independently of NF-kappa B and inflammatory changes. Am J Transplant 5 (2005) 712-719
19. Malassagne B., Taboit F., Conti F., Batteux F., Atia N., Chéreau C., et al. A newly established porcine aortic endothelial cell line: characterization and application to the study of human-to-swine graft rejection. Exp Cell Res 238 (1998) 90-100
20. Ogawa H., Muramatsu H., Kobayashi T., Morozumi K., Yokoyama I., Kurosawa N., et al. Molecular cloning of endo-beta-galactosidase C and its application in removing alpha-galactosyl xenoantigen from blood vessels in the pig kidney. J Biol Chem 275 (2000) 19368-19374
21. Vanhove B., and Bach F.H. Human xenoreactive natural antibodies-avidity and targets on porcine endothelial cells. Transplantation 56 (1993) 1251-1253
22. Persengiev S.P., Zhu X., and Green M.R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10 (2004) 12-18
23. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5 (2003) 834-839
24. Kumar P., Miller A.I., and Polverini P.J. p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J Biol Chem 279 (2004) 43352-43360
25. Secchiero P., Gonelli A., Carnevale E., Milani D., Pandolfi A., Zella D., et al. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107 (2003) 2250-2256
26. Platt J.L., Vercellotti G.M., Dalmasso A.P., Matas A.J., Bolman R.M., Najarian J.S., et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 11 (1990) 450-456 discussion 456-457
27. Tanemura M., Maruyama S., and Galili U. Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs. Transplantation 69 (2000) 187-190
28. Azimzadeh A., Wolf P., Thibaudeau K., Cinqualbre J., Soulillou J.P., and Anegon I. Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells. Transplantation 64 (1997) 1166-1174
29. Yin D.P., Sankary H.N., Ma L.L., Shen J., Qin Y., Blinder L., et al. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation 71 (2001) 1385-1389
30. Dalmasso A.P., Benson B.A., Johnson J.S., Lancto C., and Abrahamsen M.S. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 164 (2000) 3764-3773
31. Soares M.P., Seldon M.P., Gregoire I.P., Vassilevskaia T., Berberat P.O., Yu J., et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172 (2004) 3553-3563
32. Park W.D., Grande J.P., Ninova D., Nath K.A., Platt J.L., Gloor J.M., et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 3 (2003) 952-960
33. Nuutinen U., Postila V., Matto M., Eeva J., Ropponen A., Eray M., et al. Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line. Exp Cell Res 312 (2006) 322-330
34. Black S.M., Grehan J.F., Rivard A.L., Benson B.A., Wahner A.E., Koch A.E., et al. Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human complement. J Immunol 177 (2006) 7355-7363
35. Palmetshofer A., Galili U., Dalmasso A.P., Robson S.C., and Bach F.H. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. Transplantation 65 (1998) 971-978
36. Xu H., Yin D., Naziruddin B., Chen L., Stark A., Wei Y., et al. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol 170 (2003) 1531-1539
37. Lin S.S., Parker W., Everett M.L., and Platt J.L. Differential recognition by proteins of alpha-galactosyl residues on endothelial cell surfaces. Glycobiology 8 (1998) 433-443
38. Taylor S.G., McKenzie I.F., and Sandrin M.S. Characterization of the rat alpha(1,3)galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways. Glycobiology 13 (2003) 327-337
39. Milland J., Christiansen D., Lazarus B.D., Taylor S.G., Xing P.X., and Sandrin M.S. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol 176 (2006) 2448-2454